By Sagar Shankaran, Founder of CallSphere
OpenEvidence's clinical decision agent now serves 800,000+ US physicians in 2026. We profile the product, the free-vs-paid model, the citation discipline.
Key takeaways
Between April 5 and May 5, 2026, the healthcare AI agent market produced more substantive announcements than the previous 90 days combined. The signal-to-noise ratio is bad if you read every press release. We've cut through it to the deployments that are actually live, the dollar numbers that are actually documented, and the architectural decisions that buyers actually need to make in the next two quarters.
This post focuses on OpenEvidence specifically — the announcement, the customer impact, the pricing, the procurement implications, and what to do about it if you're inside an organization weighing a similar move.
The pricing math for healthcare AI agents in 2026 has settled into three patterns that show up in nearly every deal we've reviewed:
Enterprise buyers are increasingly demanding hybrid contracts — a small platform fee plus per-outcome usage — to align vendor incentives with customer success without runaway exposure to top-line conversation volume variability. The smartest contracts include caps, floors, and explicit definitions of "resolved" written in plain language.
Hear it before you finish reading
Talk to a live CallSphere AI voice agent in your browser — 60 seconds, no signup.
The unbundling pattern across healthcare AI agent platforms in 2026 is consistent:
The economics for the vendor are heavily weighted toward the add-ons. Most enterprise contracts end up 60-70% bundled and 30-40% add-on by spend. Your starting position in negotiation should be 90% bundled, with the explicit understanding that you'll concede on some add-ons but not all.
The healthcare vertical has agent-deployment specifics that don't show up in horizontal coverage and matter at procurement:
The vendors winning in healthcare are the ones that built around these constraints from day one rather than retrofitting them onto a horizontal platform after the fact.
Three forces shape vendor selection in this segment in 2026, in roughly this order of importance:
Vendors winning new business in 2026 lead with reference architecture diagrams from named customers, not feature checklists. The shift in sales motion is visible across every category.
Still reading? Stop comparing — try CallSphere live.
CallSphere ships complete AI voice agents per industry — 14 tools for healthcare, 10 agents for real estate, 4 specialists for salons. See how it actually handles a call before you book a demo.
For teams that want this kind of voice and chat agent capability without an enterprise platform commitment, CallSphere ships a turnkey AI agent platform with the same model routing, integrations, and compliance controls in a single SKU. Worth a look alongside the named vendors above.
What is the typical time-to-deploy for an enterprise healthcare AI agent in 2026? Four to ten weeks for a tier-1 intent. Most of the time is in knowledge base curation and escalation rule definition, not the model integration itself. Teams that have done it before move faster on the second use case.
What's a reasonable per-conversation cost for a production healthcare AI agent? Between $0.20 and $1.50 depending on model choice, conversation length, tool-call complexity, and channel. Voice agents typically run 2-3x chat agents on a per-conversation basis because of the speech-to-text and text-to-speech overhead.
Should we build or buy an agent platform in 2026? For most teams, buy. Build only if you have a five-plus engineer AI platform team and a 24-month commitment. The reference architecture, model routing, observability, and compliance work in a buy is more than most teams realize until they try.
How do we evaluate vendors apples-to-apples in an RFP? Insist on a 30-day pilot with your real data, your real intents, and your real evaluation criteria — not the vendor's standard pilot. Most vendors will agree if you push. The ones that won't, drop from the shortlist.
Written by
Sagar Shankaran· Founder, CallSphere
Sagar Shankaran is the founder of CallSphere, where he builds production AI voice and chat agents deployed across healthcare, hospitality, real estate, and home services. He writes about agentic AI, LLM engineering, and shipping voice agents that handle real calls in production.
See how AI voice agents work for your industry. Live demo available -- no signup required.
A three-way comparison of Gemini Enterprise, Anthropic managed agents and OpenAI Frontier Platform after Cloud Next 2026 — strengths, gaps, buyer fit.
ServiceNow Project Arc vs Anthropic Managed Agents — runtime, governance, integration, and use cases. The 2026 enterprise autonomous agent comparison.
Working memory, permanent memory, sandboxes, harnesses, governance — the practical blueprint enterprises are using to ship long-horizon AI agents in 2026.
A2A unlocks cross-vendor agent coordination, but most enterprise voice/chat workloads still ship faster on a single-vendor stack. Here is how to choose.
Anthropic confirmed JPMorgan Chase, Goldman Sachs, Citi, AIG, and Visa in production on Claude as of May 2026. What each pattern of usage looks like.
AI Control Tower is the governance layer for ServiceNow's Project Arc — policy, monitoring, and audit logs for autonomous agents. Here is how it works.
© 2026 CallSphere LLC. All rights reserved.